Aerovant: Completed Phase IIb enrollment

Aerovance completed enrollment of about 540 patients in the double-blind, placebo-controlled, U.S. and European Phase llb AeroTrial trial evaluating 1, 3 or 10 mg inhaled Aerovant given twice daily fo...